rs143697995
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_022915.5(MRPL44):c.467T>C(p.Leu156Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000936 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L156R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_022915.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MRPL44 | NM_022915.5 | c.467T>C | p.Leu156Pro | missense_variant | 2/4 | ENST00000258383.4 | |
MRPL44 | XM_011511668.3 | c.425T>C | p.Leu142Pro | missense_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MRPL44 | ENST00000258383.4 | c.467T>C | p.Leu156Pro | missense_variant | 2/4 | 1 | NM_022915.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000986 AC: 15AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251422Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135880
GnomAD4 exome AF: 0.0000930 AC: 136AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.000105 AC XY: 76AN XY: 727238
GnomAD4 genome ? AF: 0.0000986 AC: 15AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74354
ClinVar
Submissions by phenotype
Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 13, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jun 02, 2021 | This variant is present in population databases (rs143697995, ExAC 0.01%). This sequence change replaces leucine with proline at codon 156 of the MRPL44 protein (p.Leu156Pro). The leucine residue is moderately conserved and there is a moderate physicochemical difference between leucine and proline. This variant has not been reported in the literature in individuals with MRPL44-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Leu156 amino acid residue in MRPL44. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23315540, 25797485). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at